(MedPage Today) — A blood test for early-stage pancreatic cancer performed well in preliminary studies involving samples from patients with known diagnostic status.
In a blinded retrospective study, the test achieved 98% specificity and 73% sensitivity…
Source link : https://www.medpagetoday.com/hematologyoncology/othercancers/114197
Author :
Publish date : 2025-02-12 22:41:44
Copyright for syndicated content belongs to the linked Source.
